Systemic Lupus Erythematosus
684
120
153
297
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
111 trials with published results (16%)
Research Maturity
297 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.5%
51 terminated out of 684 trials
85.3%
-1.2% vs benchmark
14%
96 trials in Phase 3/4
37%
111 of 297 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 297 completed trials
Clinical Trials (684)
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
JBT-101 in Systemic Lupus Erythematosus (SLE)
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Study of Systemic Lupus Erythematosus
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
A Study of E6742 in Participants With Systemic Lupus Erythematosus
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)